| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80c161e2f67152e2918a185e322177c2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01G15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0035 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-86 |
| filingDate |
2021-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a467260f087bb3cd50cf067e80a7f93d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_def5f3b84ea7db428bb055dfda989b0f |
| publicationDate |
2021-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2021130675-A |
| titleOfInvention |
Methods and kits for preparing radionuclide complexes |
| abstract |
PROBLEM TO BE SOLVED: To provide a method for preparing a complex containing a radioisotope of gallium for use in a radiotherapy method or a medical imaging method. An optional amount of gallium radioisotope solution obtained directly from a gallium radionuclide generator, with a pharmaceutically acceptable buffer, in an amount sufficient to raise the pH to a level in the range of 3-8. It comprises the step of selectively adding to the composition containing a pharmaceutically acceptable basic reagent, wherein the composition can chelate the radioactive gallium within the pH range and at a moderate temperature. A method that further comprises a capable chelating agent, wherein the chelating agent is optionally associated with a biological targeting agent. [Selection diagram] None |
| priorityDate |
2015-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |